(2026). Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective. ClinicoEconomics and Outcomes Research.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Semaglutide 2.4 Mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective."
ClinicoEconomics and Outcomes Research 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Semaglutide 2.4 Mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective."
ClinicoEconomics and Outcomes Research, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.